Top

Annals of Surgical Oncology

Published in:

01-05-2010 | Gastrointestinal Oncology

Suitability of 7th UICC N Stage for Predicting the Overall Survival of Gastric Cancer Patients After Curative Resection in China

Authors: Jingyu Deng, MD, Han Liang, MD, Dan Sun, MS, Dianchang Wang, MD, Yi Pan, MD

Published in: Annals of Surgical Oncology | Issue 5/2010

Abstract

Background

Metastatic lymph node count (MLNC) is the most intensively prognostic indicator of gastric cancer. How to efficiently evaluate the best classification of MLNC is unclear. The purpose of this study was to evaluate the overall survival (OS) prediction of new UICC N stage in gastric cancer after curative surgery.

Materials and Methods

Data from 456 patients who underwent curative resection were used to choose the most efficient classification of MLNC for evaluation the OS of gastric cancer.

Results

Using univariate analysis, both the N stage of 7th edition UICC TNM classification (7th UICC N stage) and N stage of 5th/6th edition UICC TNM classification (5th/6th UICC N stage) were associated with the OS of gastric cancer after curative surgery. However, Cox regression multivariate analysis showed the 7th UICC N stage was an independent factor for predicting the OS of gastric cancer instead of the 5th/6th UICC N stage. Besides, we used the case-control matched fashion for further validation of the superiority of the 7th UICC N stage in prognostic prediction of gastric cancer. Last, we adopted the cut-point survival analysis to determine the most appropriate cutoffs for MLNC of all gastric cancer patients after curative surgery. We demonstrated the cutoff of 7th UICC N stage was similar to that produced from the cut-point survival analysis.

Conclusion

The 7th UICC N stage appears to provide a reliable prognostic category of MLNC of gastric cancer than the 5th/6th UICC N stage, and it is the efficiently prognostic indicator of gastric cancer after curative surgery.

Abe N, Watanabe T, Suzuki K, Machida H, Toda H, Nakaya Y, et al. Risk factors predictive of lymph node metastasis in depressed early gastric cancer. Am J Surg. 2002;183:168–72.CrossRefPubMed

Yamaguchi T, Sano T, Katai H, Sasako M, Maruyama K. Node positive mucosal gastric cancer: a follow-up study. Jpn J Clin Oncol. 2001;31:153–6.CrossRefPubMed

Chen CY, Wu CW, Lo SS, Hsieh MC, Lui WY, Shen KH. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma. Hepatogastroenterology. 2002;49:874–7.PubMed

Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, et al. Significant prognostic factors in patients with early gastric cancer. Int Surg. 2000;85:286–90.PubMed

Manfe AZ, Segalina P, Maffei Faccioli A. Prognostic factors in gastric cancer. Our experience and review of the literature. Minerva Chir. 2000;55:299–305.PubMed

Omejc M, Juvan R, Jelenc F, Repse S. Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg. 2001;86:14–9.PubMed

Kajitani T. Japanese Research Society for Gastric Cancer: the general rules for the gastric cancer study in surgery and pathology. I. Jpn J Surg. 1981;11:127–139.CrossRefPubMed

Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 2nd English ed. Gastric Cancer. 1998;1:10–4.

Wu CW, Hsieh MC, Lo SS, Shen KH, Lui WY, P’eng FK. Comparison of the UICC/AJCC 1992 and 1997 pN categories for gastric cancer patients after surgery. Hepatogastroenterology. 2001;48:279–84.PubMed

10.

Katai H, Yoshimura K, Maruyama K, Sasako M, Sano T. Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma. Cancer. 2000;88:1796–800.CrossRefPubMed

11.

Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Ono H, et al. Comparative evaluation of gastric carcinoma staging: Japanese classification versus new American joint committee on cancer/international union against cancer classification. Ann Surg Oncol. 2004;11:203–6.CrossRefPubMed

12.

Fujii K, Isozaki H, Okajima K, Nomura E, Niki M, Sako S, et al. Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system. Br J Surg. 1999;86:685–9.CrossRefPubMed

13.

Ichikura T, Tomimatsu S, Uefuji K, Kimura M, Uchida T, Morita D, et al. Evaluation of the New American Joint Committee on Cancer/International Union Against Cancer Classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer. 1999;86:5538.CrossRef

14.

Adachi Y, Kamakura T, Mori M, Baba H, Maehara Y, Sugimachi K. Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg. 1994;81:414–6.CrossRefPubMed

15.

Pan W, Ishii H, Ebihara Y, Gobe G. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins. J Surg Oncol. 2003;82:104–10.CrossRefPubMed

16.

Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer. 2006;107:2143–51.CrossRefPubMed

17.

Deng JY, Liang H, Sun D, Zhan HJ, Wang XN. The appropriate cutoffs of positive lymph nodes to evaluate the prognosis of gastric cancer patients. J Surg Oncol. 2008;98:343–8.CrossRefPubMed

18.

Fleming ID, Cooper JS, Murphy GP, Sullivan BO, Sobin LH, Yarbro JW, et al., eds. American Joint Committee on Cancer: Cancer Staging Manual. Philadelphia: Lippincott-Raven; 1997:71–6.

19.

Sobin LH, Wittekind CH, eds. TNM Classification of Malignant Tumors. 5th ed. International Union Against Cancer (UICC). New York: Wiley; 1997:59–62.

20.

Greene FL, Page AL, Fleming ID, Fritz A, Balch CM, Haller DG, et al., eds. American Joint Committee on Cancer: AJCC Cancer Staging Manual, 6th ed. New York: Springer; 2002:99–106.

21.

Sobin L, Gospodarowicz M, Wittekind C, eds. TNM Classification of Malignant Tumours. 7th ed. International Union Against Cancer (UICC). New York: Wiley; 2009.

22.

Smith DD, Schwarz RR, Schwartz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-Population Database. J Clin Oncol. 2005;23:7114–24.CrossRefPubMed

23.

Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev. 2000;26:243–55.CrossRefPubMed

24.

Dhar DK, Kubota H, Tachibana M, Kinugasa S, Masunaga R, Shibakita M, et al. Prognosis of T4 gastric carcinoma patients: an appraisal of aggressive surgical treatment. J Surg Oncol. 2001;76:278–82.CrossRefPubMed

25.

Dhar DK, Kubota H, Tachibana M, Kotoh T, Tabara H, Watanabe R, et al. Long-term survival of transmural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factors. World J Surg. 2000;24:588–93.CrossRefPubMed

26.

Gotoda T, Sasako M, Ono H, Katai H, Sano T, Shimoda T. Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer. Br J Surg. 2001;88:444–9.CrossRefPubMed

27.

Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, et al. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. Ann Surg Oncol. 2006;13:659–67.CrossRefPubMed

28.

Ohno S, Tachibana M, Shibakita M, Dhar DK, Yoshimura H, Kinugasa S, et al. Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer. Ann Surg Oncol. 2000;7:750–7.CrossRefPubMed

29.

Okajima K. Prognostic factors of gastric cancer patients-a study by univariate and multivariate analysis. Jpn J Gastroenterol Surg. 1997;30:700–11.

30.

Aiko T, Sasako M. The new Japanese Classification of Gastric Carcinoma: points to be revised. Gastric Cancer. 1998;1:25–30.CrossRefPubMed

31.

Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775–84.CrossRefPubMed

32.

Okusa T, Nakane Y, Boku T, Takada H, Yamamura M, Hioki K, et al. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet. 1990;170:488–94.PubMed

33.

Zhan YQ, Sun XW, Li W, Chen YB, Xu L, Guan YX, et al. Multivariate prognostic analysis in gastric carcinoma patients after radical operation. Ai Zheng. 2005;24:596–9.PubMed

34.

Jaehne J, Meyer HJ, Maschek H, Geerlings H, Bruns E, Pichlmayr R. Lymphadenectomy in gastric adenocarcinoma. A prospective and prognostic study. Arch Surg. 1992;127:290–4.PubMed

35.

Ikeguchi M, Murakami D, Kanaji S, Ohro S, Maeta Y, Yamaguchi KI, et al. Lymph node metastasis of gastric cancer: comparison of Union International Contra Cancer and Japanese systems. ANZ J Surg. 2004;74:852–4.CrossRefPubMed

36.

D’Ugo D, Pacelli F, Persiani R, Pende V, Ianni A, Papa V, et al. Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomy. World J Surg. 2002;26:672–7.CrossRefPubMed

37.

Huang B, Zheng X, Wang Z, Wang M, Dong Y, Zhao B, et al. Prognostic significance of the number of metastatic lymph nodes: Is UICC/TNM node classification perfectly suitable for early gastric cancer? Ann Surg Oncol. 2009;16:61–7.CrossRefPubMed

38.

Roviello F, Rossi S, Marrelli D, Pedrazzani C, Corso G, Vindigni C, et al. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol. 2006;94:274–80.CrossRef

39.

Gunji Y, Suzuki T, Hori S, Hayashi H, Matsubara H, Shimada H, et al. Prognostic significance of the number of metastatic lymph nodes in early gastric cancer. Dig Surg. 2003;20:148–53.CrossRefPubMed

40.

Wu CW, Hsieh MC, Lo SS, Tsay SH, Lui WY, P’eng FK. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut. 1996;38:525–7.CrossRefPubMed

41.

Ichikura T, Tomimatsu S, Okusa Y, Uefuji K, Tamakuma S. Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol. 1993;11:1894–900.PubMed

42.

Zhang X, David IW, Glyn GJ. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction. Chin Med J. 2007;120:2268–70.PubMed

Title: Suitability of 7th UICC N Stage for Predicting the Overall Survival of Gastric Cancer Patients After Curative Resection in China
Authors: Jingyu Deng, MD
Han Liang, MD
Dan Sun, MS
Dianchang Wang, MD
Yi Pan, MD
Publication date: 01-05-2010
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 5/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-010-0939-x

At a glance: The STEP trials

Springer Medicine

Suitability of 7th UICC N Stage for Predicting the Overall Survival of Gastric Cancer Patients After Curative Resection in China

Abstract

Background

Materials and Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Materials and Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2010

KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications

Postoperative Pancreatic Fistula After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: Incidence, Risk Factors, Management, and Clinical Sequelae

A Systematic Review and Meta-Analysis of Oncologic Outcomes of Pre- Versus Postoperative Radiation in Localized Resectable Soft-Tissue Sarcoma

Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy

Distal Pancreatectomy Combined with Celiac Axis Resection in Treatment of Carcinoma of the Body/Tail of the Pancreas: A Single-Center Experience

HLA-G Expression in Human Breast Cancer: Implications for Diagnosis and Prognosis, and Effect on Allocytotoxic Lymphocyte Response After Hormone Treatment In Vitro